Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO. / Soelberg Sorensen, Per.
I: Multiple Sclerosis, Bind 22, Nr. 10, 2016, s. 1260-1263.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Soelberg Sorensen, P 2016, 'Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO', Multiple Sclerosis, bind 22, nr. 10, s. 1260-1263. https://doi.org/10.1177/1352458516644341
APA
Soelberg Sorensen, P. (2016). Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO. Multiple Sclerosis, 22(10), 1260-1263. https://doi.org/10.1177/1352458516644341
Vancouver
Soelberg Sorensen P. Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO. Multiple Sclerosis. 2016;22(10):1260-1263. https://doi.org/10.1177/1352458516644341
Author
Bibtex
@article{6df5658212c149a79a051657a1714009,
title = "Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO",
author = "{Soelberg Sorensen}, Per",
year = "2016",
doi = "10.1177/1352458516644341",
language = "English",
volume = "22",
pages = "1260--1263",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "10",
}
RIS
TY - JOUR
T1 - Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO
AU - Soelberg Sorensen, Per
PY - 2016
Y1 - 2016
U2 - 10.1177/1352458516644341
DO - 10.1177/1352458516644341
M3 - Journal article
C2 - 27444559
AN - SCOPUS:84986569338
VL - 22
SP - 1260
EP - 1263
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 10
ER -
ID: 179090275